Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical phenytoin and loperamide for post-herpetic neuralgia
ISRCTN18843536Phase 2Completed
- Sponsor
- University Clinical Centre Maribor
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing Topical phenytoin + loperamide cream with Placebo cream (2 arms). Primary endpoint: Pain severity by Numeric Rating Scale at 14 days. Started Mar 2024; status: completed.
02
Drugs
phenytoinloperamide
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on ISRCTN18843536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18843536.